[{"id":"90768b89-c427-470b-b45e-d036704acad6","acronym":"","url":"https://clinicaltrials.gov/study/NCT03093155","created_at":"2024-05-05T01:48:26.040Z","updated_at":"2024-07-02T16:35:03.705Z","phase":"Phase 2","brief_title":"Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab","source_id_and_acronym":"NCT03093155","lead_sponsor":"Yale University","biomarkers":" TUBB3","pipe":"","alterations":" ","tags":["TUBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Avastin (bevacizumab) • Ixempra (ixabepilone)"],"overall_status":"Completed","enrollment":" Enrollment 78","initiation":"Initiation: 04/03/2017","start_date":" 04/03/2017","primary_txt":" Primary completion: 12/29/2022","primary_completion_date":" 12/29/2022","study_txt":" Completion: 12/29/2022","study_completion_date":" 12/29/2022","last_update_posted":"2024-05-14"},{"id":"9b8f0668-89c2-4a17-b398-80a6f02ea55e","acronym":"","url":"https://clinicaltrials.gov/study/NCT01865045","created_at":"2021-01-18T08:20:35.723Z","updated_at":"2024-07-02T16:36:04.175Z","phase":"","brief_title":"Pharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients","source_id_and_acronym":"NCT01865045","lead_sponsor":"Armando Santoro, MD","biomarkers":" BRCA1 • TUBB3","pipe":" | ","alterations":" BRCA1 expression • TUBB3 expression","tags":["BRCA1 • TUBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA1 expression • TUBB3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e vinorelbine tartrate"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 11/01/2012","start_date":" 11/01/2012","primary_txt":" Primary completion: 12/01/2016","primary_completion_date":" 12/01/2016","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2022-09-10"}]